Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $8.789B (98.4% shares, 1.6% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 36,179,122 | $2.272B | 25.8% | $72.80 | -22.3% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 10,568,897 | $1.906B | 21.7% | $136.93 | — | SPONSORED ADR | 07725L102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 42,864,612 | $1.342B | 15.3% | $18.93 | +26.2% | COM | 004225108 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,969,798 | $456M | 5.2% | $119.77 | +46.1% | COM | 558868105 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 6,398,365 | $294M | 3.3% | $23.49 | +34.3% | COM | 76243J105 |
| — | Mirati Therapeutics, Inc. | 4,121,440 | $242M | 2.8% | $46.47 | — | COM | 60468T105 |
| IMCR | Immunocore Holdings plc | 2,520,731 | $172M | 2.0% | $42.57 | — | ADS | 45258D105 |
| KYMR | Kymera Therapeutics, Inc. | 5,995,928 | $153M | 1.7% | $28.14 | -36.4% | COM | 501575104 |
| RVMD | Revolution Medicines, Inc. | 5,148,657 | $148M | 1.7% | $25.21 | -4.7% | COM | 76155X100 |
| — | Invitae Corporation | 300,000,000 | $131M | 1.5% | $0.45 | — | Notes 1.5% 4/1/2028 | 46185LAD5 |
| ABCL | AbCellera Biologics Inc. | 22,909,753 | $131M | 1.5% | $24.23 | -80.9% | COM | 00288U106 |
| ROIV | Roivant Sciences Ltd. | 7,593,024 | $85.27M | 1.0% | $8.98 | +8.5% | SHS | G76279101 |
| REPL | Replimune Group, Inc. | 9,545,336 | $80.47M | 0.9% | $15.29 | -24.2% | COM | 76029N106 |
| TRDA | Entrada Therapeutics, Inc. | 4,865,819 | $73.43M | 0.8% | $16.96 | — | COM | 29384C108 |
| RARE | Ultragenyx Pharmaceutical Inc. | 1,466,547 | $70.13M | 0.8% | $65.34 | -40.7% | COM | 90400D108 |
| — | Cerevel Therapeutics Holdings, Inc. | 1,600,000 | $67.84M | 0.8% | $42.40 | — | COM | 15678U128 |
| IMTX | Immatics N.V. | 5,838,853 | $61.48M | 0.7% | $10.79 | -14.7% | SHS | N44445109 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 10,126,176 | $60.66M | 0.7% | $6.35 | -8.8% | COM | 09058V103 |
| ARGX | argenx SE | 151,215 | $57.53M | 0.7% | $79.01 | — | SPONSORED ADR | 04016X101 |
| DNLI | Denali Therapeutics Inc. | 2,607,196 | $55.95M | 0.6% | $25.93 | -23.6% | COM | 24823R105 |
| — | Akero Therapeutics, Inc. | 2,368,378 | $55.3M | 0.6% | $33.89 | — | COM | 00973Y108 |
| KOD | Kodiak Sciences Inc. | 17,310,490 | $52.62M | 0.6% | $30.30 | -92.7% | COM | 50015M109 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,809,577 | $49.28M | 0.6% | $17.35 | — | COM CL A | G5269C101 |
| XENE | Xenon Pharmaceuticals Inc. | 993,679 | $45.77M | 0.5% | $18.51 | +90.9% | COM | 98420N105 |
| PRLD | Prelude Therapeutics Inc. | 10,123,824 | $43.23M | 0.5% | $28.24 | -89.2% | COM | 74065P101 |
| CERS | Cerus Corporation | 19,477,339 | $42.07M | 0.5% | $4.19 | -60.6% | COM | 157085101 |
| NRIX | Nurix Therapeutics, Inc. | 3,882,125 | $40.06M | 0.5% | $22.27 | -69.2% | COM | 67080M103 |
| — | Aerovate Therapeutics, Inc. | 1,680,517 | $38.03M | 0.4% | $21.15 | — | COM | 008064107 |
| IDYA | IDEAYA Biosciences, Inc. | 1,062,123 | $37.79M | 0.4% | $14.62 | +104.1% | COM | 45166A102 |
| EWTX | Edgewise Therapeutics, Inc. | 3,112,786 | $34.05M | 0.4% | $11.06 | -36.5% | COM | 28036F105 |
| SERA | Sera Prognostics, Inc. | 5,434,399 | $32.5M | 0.4% | $3.07 | -5.4% | CLASS A COM | 81749D107 |
| BCYC | Bicycle Therapeutics plc | 1,790,390 | $32.37M | 0.4% | $20.52 | — | SPONSORED ADS | 088786108 |
| — | IGM Biosciences, Inc. | 3,691,011 | $30.67M | 0.3% | $16.39 | — | COM | 449585108 |
| BMEA | Biomea Fusion, Inc. | 2,108,949 | $30.62M | 0.3% | $8.56 | +41.9% | COM | 09077A106 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4,916,095 | $27.78M | 0.3% | $6.49 | -39.6% | COM | 61225M102 |
| — | Verve Therapeutics, Inc. | 1,691,530 | $23.58M | 0.3% | $52.72 | — | COM | 92539P101 |
| KRYS | Krystal Biotech, Inc. | 169,934 | $21.08M | 0.2% | $34.45 | +221.9% | COM | 501147102 |
| — | Gracell Biotechnologies Inc. | 2,080,000 | $20.88M | 0.2% | $7.04 | — | SPONSORED ADS | 38406L103 |
| IMVT | Immunovant, Inc. | 425,009 | $17.91M | 0.2% | $22.60 | +62.8% | COM | 45258J102 |
| TCRX | TScan Therapeutics, Inc. | 2,784,792 | $16.24M | 0.2% | $6.08 | -24.7% | COM | 89854M101 |
| DAWN | Day One Biopharmaceuticals, Inc. | 1,000,000 | $14.6M | 0.2% | $13.06 | -7.2% | COM | 23954D109 |
| — | DBV Technologies S.A. | 14,614,264 | $13.92M | 0.2% | $19.06 | — | SPONSORED ADR | 23306J101 |
| RLAY | Relay Therapeutics, Inc. | 1,160,117 | $12.77M | 0.1% | $13.78 | -38.8% | COM | 75943R102 |
| SPRY | ARS Pharmaceuticals, Inc. | 2,006,451 | $11M | 0.1% | $6.49 | -32.5% | COM | 82835W108 |
| STOK | Stoke Therapeutics, Inc. | 2,030,134 | $10.68M | 0.1% | $8.98 | -52.4% | COM | 86150R107 |
| — | 2seventy bio, Inc. | 2,497,526 | $10.66M | 0.1% | $18.72 | — | COM | 901384107 |
| INSM | Insmed Incorporated | 343,000 | $10.63M | 0.1% | $19.59 | +32.4% | COM PAR $.01 | 457669307 |
| CLDX | Celldex Therapeutics, Inc. | 247,644 | $9.822M | 0.1% | $29.41 | 0.0% | COM | 15117B202 |
| PRME | Prime Medicine, Inc. | 1,028,466 | $9.112M | 0.1% | $18.06 | -57.4% | COM | 74168J101 |
| NGNE | Neurogene Inc. | 453,516 | $8.789M | 0.1% | $14.32 | 0.0% | COM | 64135M105 |
| ADAPY | Adaptimmune Therapeutics plc | 10,969,282 | $8.699M | 0.1% | $5.27 | — | SPONSORED ADR | 00653A107 |
| SANA | Sana Biotechnology, Inc. | 2,000,000 | $8.16M | 0.1% | $4.00 | -7.8% | COM | 799566104 |
| SGMT | Sagimet Biosciences Inc. | 1,456,518 | $7.894M | 0.1% | $9.53 | -50.5% | COM SER A | 786700104 |
| CELC | Celcuity Inc. | 535,478 | $7.802M | 0.1% | $9.83 | +22.8% | COM | 15102K100 |
| — | Athira Pharma, Inc. | 3,153,807 | $7.664M | 0.1% | $6.91 | — | COM | 04746L104 |
| OPTEY | Opthea Limited | 2,588,645 | $7.637M | 0.1% | $11.12 | — | SPONSORED ADS | 68386J208 |
| TNGX | Tango Therapeutics, Inc. | 750,000 | $7.425M | 0.1% | $11.99 | -27.6% | COM | 87583X109 |
| TSHA | Taysha Gene Therapies, Inc. | 4,004,756 | $7.088M | 0.1% | $1.91 | +4.1% | COM SHS | 877619106 |
| — | HOOKIPA Pharma Inc. | 8,128,151 | $6.584M | 0.1% | $1.55 | — | COM | 43906K100 |
| — | Invitae Corporation | 9,274,000 | $6.273M | 0.1% | $0.67 | — | Series A Notes 4.5% 3/15/2028 | 46185LAH6 |
| MIRM | Mirum Pharmaceuticals, Inc. | 190,476 | $5.623M | 0.1% | $27.38 | +10.5% | COM | 604749101 |
| XNCR | Xencor, Inc. | 245,431 | $5.21M | 0.1% | $23.51 | -19.1% | COM | 98401F105 |
| CYPH | Leap Therapeutics, Inc. | 1,172,175 | $4.859M | 0.1% | $5.02 | -56.9% | COM | 52187K200 |
| DSGN | Design Therapeutics, Inc. | 1,500,000 | $3.975M | 0.0% | $13.49 | -83.0% | COM | 25056L103 |
| TLIS | Talis Biomedical Corporation | 508,323 | $3.787M | 0.0% | $7.25 | -10.2% | COM | 87424L207 |
| — | Perspective Therapeutics, Inc. | 7,639,703 | $3.071M | 0.0% | $0.39 | — | COM | 46489V104 |
| PCVX | Vaxcyte, Inc. | 48,885 | $3.07M | 0.0% | $39.24 | +32.3% | COM | 92243G108 |
| — | Praxis Precision Medicines, Inc. | 131,533 | $2.931M | 0.0% | $2.34 | — | COM | 74006W108 |
| IPSC | Century Therapeutics, Inc. | 797,460 | $2.648M | 0.0% | $9.79 | -81.4% | COM | 15673T100 |
| — | Mersana Therapeutics, Inc. | 1,086,115 | $2.52M | 0.0% | $4.11 | — | COM | 59045L106 |
| CMPX | Compass Therapeutics, Inc. | 1,557,630 | $2.43M | 0.0% | $3.99 | -56.6% | COM | 20454B104 |
| — | Achilles Therapeutics plc | 2,102,792 | $1.869M | 0.0% | $16.55 | — | SPONSORED ADS | 00449L102 |
| KALA | KALA BIO, Inc. | 266,613 | $1.866M | 0.0% | $11.98 | -40.9% | COM | 483119202 |
| — | Aligos Therapeutics, Inc. | 2,076,400 | $1.379M | 0.0% | $24.92 | — | COM | 01626L105 |
| — | Invitae Corporation | 1,764,546 | $1.106M | 0.0% | $24.10 | — | COM | 46185L103 |
| PFE | Pfizer Inc. | 35,000 | $1.008M | 0.0% | $26.40 | 0.0% | COM | 717081103 |
| PMVP | PMV Pharmaceuticals, Inc. | 322,024 | $998K | 0.0% | $14.45 | -81.7% | COM | 69353Y103 |
| WHWK | Aadi Bioscience, Inc. | 251,727 | $508K | 0.0% | $13.14 | -68.1% | COM | 00032Q104 |
| TARA | Protara Therapeutics, Inc. | 199,671 | $374K | 0.0% | $30.96 | -95.2% | COM STK | 74365U107 |
| CABA | Cabaletta Bio, Inc. | 13,331 | $303K | 0.0% | $8.14 | +106.6% | COM | 12674W109 |
| FHTX | Foghorn Therapeutics Inc. | 45,027 | $290K | 0.0% | $14.37 | -70.0% | COM | 344174107 |
| — | Atreca, Inc. | 2,177,499 | $287K | 0.0% | $18.84 | — | CL A COM | 04965G109 |
| TYRA | Tyra Biosciences, Inc. | 10,607 | $147K | 0.0% | $12.95 | 0.0% | COM | 90240B106 |
| SRZNW | Surrozen, Inc. | 833,333 | $16,167 | 0.0% | $1.14 | — | W EXP 8/11/2026 | 86889P117 |